🔎 Trials Near Me

Akèy › Skleroz Miltip › North Carolina

Etid klinik pou Skleroz Miltip nan North Carolina

8 etid pou Skleroz Miltip ap chèche patisipan nan sit nan North Carolina.

Vil nan North Carolina

Tèks ofisyèl etid la (Anglè)

A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)

  • Local Institution - Site 101, Raleigh
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Sep 25, 2026 · NCT07840326

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

  • TG Therapeutics Investigational Trial Site, Charlotte
  • TG Therapeutics Investigational Trial Site, New Bern
  • TG Therapeutics Investigational Trial Site, Raleigh
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06433752

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

  • Duke University, Durham
Ap rekriteFaz 1/2
Laj 18 a 65 · Tout sèks · Mizajou Sep 21, 2026 · NCT07477639

A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS)

  • BRIUMVI® Pregnancy Registry Virtual Research Coordination Center, Wilmington
Ap rekriteEtid obsèvasyon
Laj 15 a 50 · Fanm · Mizajou Sep 21, 2026 · NCT06433765

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

  • Piedmont HealthCare - Lake Norman Neurology- Site Number : 8400002, Charlotte
  • Raleigh Neurology Associates- Site Number : 8400014, Raleigh
Ap rekriteFaz 3
Laj 18 a 60 · Tout sèks · Mizajou Sep 15, 2026 · NCT07325292

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • University of North Carolina at Chapel Hill, Chapel Hill
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034

Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)

  • IQVIA US Office, Durham
Ap rekriteEtid obsèvasyon
Tout laj · Fanm · Mizajou Aug 11, 2026 · NCT05658497

Retinal Imaging in Neurodegenerative Disease

  • Duke University Medical Center, Durham
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Feb 4, 2026 · NCT03233646

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.